Table 1 |
|
|
Drug use indicators derived from questionnaire |
|
|
Objective of malaria drug policy |
Indicator |
|
|
|
|
Increase treatment from trained provider |
% of people with fever who went to a trained provider |
|
Increase use of biological diagnosis |
% of people with fever who had a biological diagnosis |
|
Reduce delay in treatment |
% of people who receive modern drugs within 48 hours of symptoms |
|
Correct drug choice |
% of first-line drug (artesunate and mefloquine) as proportion of modern drugs |
|
Decrease use of artemisinin monotherapy |
% of artemisinin monotherapy as a proportion of all artemisinin use |
|
Adherence to ACT |
% of people who take artesunate and mefloquine for at least 3 days |
|
Reduce patient costs |
Median drug cost of treatment |
|
|
|
|
Yeung et al. Malaria Journal 2008 7:96 doi:10.1186/1475-2875-7-96 |
|